Vaccination News Home Page

http://www.bt.cdc.gov/agent/smallpox/vaccination/section-304-qa.asp

Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
Public Health Emergency Preparedness & Response
Links to Home and Contact Us
Public Health Emergency Preparedness & Response Home Search Contact Us
Department of Health and Human Services
Agents & Threats
  Biological (Listing)
     Smallpox  
       Smallpox Basics  
         En Español  
       In-Depth Info & Resources  
         Diagnosis/
Evaluation
 
         Exposure Management  
         Images  
         Infection Control  
         Lab Testing  
         Preparation & Planning  
         Reference Materials  
         Surveillance & Investigation  
         Training  
         Vaccination  
   Chemical (Listing)  
   Radiological Emergencies  
Site Topics
   Preparation & Planning  
   Emergency Response  
   Lab Information  
   Surveillance  
   News & Media Relations  
   Training  
   Resources/Links  
   FAQ  
En Español
   Página Principal de Terrorismo Biológico  

 
Public Inquiries
English (888) 246-2675
Español (888) 246-2857
TTY (866) 874-2646
Mon-Fri 8am-11pm EST
Sat-Sun 10am-8pm EST

Centers for Disease Control and Prevention
1600 Clifton Rd.
Atlanta, GA 30333
USA
(404) 639-3311
FirstGov
Smallpox Home > In-Depth Info & Resources > Vaccination >
SMALLPOX QUESTIONS AND ANSWERS
Section 304 of the Homeland Security Act (Liability Issues)
Download PDF version formatted for print Adobe Acrobat Reader (110 KB/3 pages)

GENERAL

Q.1. What is the purpose of Section 304 of the Homeland Security Act?

A.1. Manufacturers of smallpox vaccine and those healthcare entities that would administer the vaccine have raised concerns about their potential liability for involvement in a federal smallpox vaccination campaign. Section 304 of the Homeland Security Act is intended to alleviate these liability concerns and therefore ensure that vaccine is available and can be administered, particularly in the event of a smallpox-related actual or potential public health emergency such as a bioterrorist incident.

Q.2. In general, what does Section 304 provide?

A.2. Section 304 provides an exclusive remedy against the United States for injury or death attributable to smallpox vaccine, other substances used to treat or prevent smallpox, or vaccinia immune globulin ("smallpox countermeasures"). This means that no claim for liability for injury or death attributable to a smallpox countermeasure could be brought against entities or individuals who are covered by Section 304's protections.

Q.3. When do the provisions of Section 304 become effective?

A.3. The effective date, as established in Section 4 of the Homeland Security Act, is January 24, 2003. If vaccination is to begin sooner, Section 304 would apply at that earlier time only if Congress enacts legislation moving up the effective date.

FILING A CLAIM

Flowchart: Liability Protection for Injury Claims Arising out of Smallpox Countermeasures
View full-size flowchart: Liability Protection for Injury Claims Arising out of Smallpox Countermeasures
View full-size flowchart.

Q.4. If I am injured as a result of receiving a smallpox countermeasure, how do I know if I can file a Section 304 claim?

A.4. Section 304 is triggered if and when a smallpox countermeasure is administered pursuant to a declaration by the Secretary of Health and Human Services. The declaration will specify the administration of particular countermeasures to one or more categories of individuals, and it will state how long it is in effect. An individual described in the declaration who receives one of those countermeasures from a qualified person while the declaration is in effect, and who is injured as a result, may file a claim under Section 304.

Q.5. Who is a "qualified person?"

A.5. Qualified persons are licensed health professionals or other individuals authorized to administer smallpox countermeasures under state law. Section 304 claims may be filed for injuries due to administration of countermeasures only if the countermeasure is administered by a qualified person.

Q.6. If I contract vaccinia without having received smallpox vaccine, can I file a Section 304 claim?

A.6. Individuals who were not inoculated, but who nonetheless contract vaccinia during the period of the Secretary’s declaration or 30 days thereafter, or who reside or resided with an individual who was inoculated pursuant to the declaration, may submit claims.

Q.7. What is the process for filing a Section 304 claim?

A.7. Anyone who believes he or she has a claim for money damages attributable to injury or death due to smallpox countermeasures must submit an administrative claim with an appropriate agency of the United States within two years. If the agency denies the claim, or if no action is taken on the claim within six months, the injured individual may file suit in federal court.

Q.8. May the Secretary make the declaration prior to the occurrence of a bioterrorist incident or public health emergency?

A.8. A declaration can be made if the Secretary concludes that an actual or potential bioterrorist incident or other actual or potential public health emergency makes the administration advisable. The Secretary can, therefore, make the declaration prior to the occurrence of a bioterrorist incident or public health emergency.

COVERED ENTITIES

Q.9. What entities are covered by Section 304's protections?

A.9. With respect to administration of a covered countermeasure, manufacturers and distributors of countermeasures, healthcare entities under whose auspices the countermeasure is administered, and licensed health care professionals or other individuals authorized to administer the countermeasure under state law are covered by Section 304. In addition, any official, agent, or employee of any of these entities is also covered.

Q.10. Are state and local health departments and their employees covered by Section 304?

A.10. State and local health departments that act as distributors of countermeasures or that are healthcare entities under whose auspices countermeasures are administered are covered by Section 304. Their officials, agents, or employees are also covered for actions arising out of the administration of a countermeasure.

Q.11. Does Section 304 contain any limitations for covering these entities?

A.11. If a claim under Section 304 is based on an action or omission by a particular manufacturer, health care professional, or other person listed under item A.9 above, and that person fails to cooperate with the Government in the defense of the claim, the United States will not be liable for any damages resulting from that person’s act or omission.

Also, if the United States makes a payment on a claim, and the payment is based (partly or wholly) on gross negligence, recklessness, illegal conduct, or willful misconduct by the manufacturer, health care professional, or other person listed under item A.9, or based on the person's violation of a contract with the United States, the United States may recover that portion of the payment (with interest and litigation costs) from that person.

OTHER

Q.12. What effect does Section 304 have upon federal or state workers' compensation schemes?

A.12. Workers covered by state workers' compensation statutes who suffer work-related injuries from the countermeasure may be barred from submitting a Section 304 claim if those state laws constitute an exclusive remedy. Federal employees who suffer such work-related injuries may only file claims pursuant to the Federal Employees' Compensation Act.

Q.13. What legal standards apply to Section 304 claims?

A.13. In general, suits would be governed by state law as to liability and damages, except when provisions of the federal law provided otherwise. For example, a claimant must demonstrate that the injury or death attributable to the countermeasure was the result of a negligent or wrongful act or omission, regardless of the standard in the state where the act or omission occurred.

Q.14. Does the statute authorize payment for lost time from work or health care costs necessary for treating the injury?

A.14. If a claimant prevails on a Section 304 claim, damages would be determined according to state law, within any limits imposed by federal law. While loss of income and health care costs generally are recoverable, Section 304 does not establish a "no-fault" compensation program. See items A.2 and A.13. Individuals may wish to review their health insurance policies to determine whether they cover health-care costs for injuries attributable to administration of a smallpox countermeasure. For information on Section 304's interaction with workers' compensation claims, see item A.12.

Q.15. Are all persons working in a vaccination clinic covered by Section 304?

A.15. A vaccination clinic, as a healthcare entity under whose auspices a countermeasure is administered, is covered by Section 304 protections. Any official, employee, or agent of such a vaccination clinic would therefore also be covered by Section 304 protections for actions arising out of the administration of a countermeasure. See item A.9.

Q.16. Will hospitals or other institutions who employ vaccinees but who do not operate as a clinic administering countermeasures be covered by Section 304 protections?

A.16. Generally, no. Only hospitals and institutions under whose auspices countermeasures are administered are covered by Section 304 protections.

 Top of Page


Home |SearchContact Us

CDC Home | CDC Search | Health Topics A-Z

In general, all information presented in these pages and all items available for download are for public use. However, you may encounter some pages that require a login password and ID. If this is the case, you may assume that information presented and items available for download therein are for your authorized access only and not for redistribution by you unless you are otherwise informed.

  Page last modified December 5, 2002
    Privacy Policy | Accessibility
    

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.